VASCULAR COMORBIDITY - A NEW TREND IN OUTPATIENT CARE
- Autores: Khovasova N.O.1, Vertkin A.L.1
-
Afiliações:
- A.I. Evdokimov Moscow State University of Medicine and Dentistry
- Edição: Nº 1 (2015)
- Páginas: 38-44
- Seção: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/277243
- ID: 277243
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Clinical observation of a typical case of vascular comorbidity (VC, hypertension, myocardial infarction, atrial fibrillation) in a patient 68 years old with a fatal outcome is presented. The major elements in the formation of the VC are hypertension and atherosclerosis - pathological conditions that trigger the development of cardiovascular continuum and are characterized by multi-organ changes. Universal mechanism of VC is endothelial dysfunction that triggers a cascade of pathological vascular changes. The most important underlying disease leading to endothelial dysfunction is type 2 diabetes. The features of the VC in the Russian Federation are presented. It is emphasized that early detection of risk factors, adequate and regular monitoring of district physician and timely comprehensive treatment of the VC are the main objectives of outpatient care.
Palavras-chave
Texto integral
Sobre autores
Nataliya Khovasova
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Email: natashahov@mail.ru
PhD, Associate Professor, Department of Therapy, Clinical Pharmacology and Emergency Medical Care 127473 Moscow, 20/1, Delegatskaya st
Arkady Vertkin
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Email: kafedrakf@mail.ru
MD, Professor, Head of Department of Therapy, Clinical Pharmacology and Emergency Medical Care 127473 Moscow, 20/1, Delegatskaya st
Bibliografia
- Калвиньш И.Я. Милдронат: механизм действия и перспективы его применения. Рига, 2002.
- Дамброва М., Дайя Д., Лиепиньш Э., Кирьянова О., Калвиньш И. Биохимические механизмы действия милдроната в условиях ишемического стресса. Врачебное дело. 2004;2:68-74.
- Eastaugh J.L., Calvert M.J., Freemantle N. Highlighting the need for better patient care instable angina: results of the international Angina Treatment Patterns (ATP) Survey in 7074 patients. Fam. Pract. 2005;22(1):43-50.
- Dambrova M., Skapare-Makarova E., Konrade I. Meldonium decreases the diet-increased plasma levels of trimethylamine N-oxide, a metabolite associated with atherosclerosis. J Clin Pharmacol. 2013;53:1095-1098.
Arquivos suplementares
